National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:14:55

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59011-263-10	EA - Each	59011-263	1a0823cc-e580-453e-8cae-e8ed4ecee1c1	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
59011-263	59011-263-10

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N019516-001	MS CONTIN	MORPHINE SULFATE	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29
N019516-002	MS CONTIN	MORPHINE SULFATE	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08
N019516-003	MS CONTIN	MORPHINE SULFATE	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12
N019516-004	MS CONTIN	MORPHINE SULFATE	100MG	TABLET, EXTENDED RELEASE / ORAL		RLD	1990-01-16
N019516-005	MS CONTIN	MORPHINE SULFATE	200MG	TABLET, EXTENDED RELEASE / ORAL		RLD	1993-11-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N019516-001	AB
N019516-002	AB
N019516-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 220 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL		RLD	1990-01-16	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL		RLD	1993-11-08	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019516-001	MS CONTIN	30MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1987-05-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019516-002	MS CONTIN	60MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1988-04-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019516-003	MS CONTIN	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1989-09-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019516-004	MS CONTIN	100MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	1990-01-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N019516-005	MS CONTIN	200MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD	1993-11-08	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Normalized TE history page 6 of 6 · 218 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-10-28 04:53 UTC	2022-10	N019516-003	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N019516-004	AB	1	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N019516-005	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N019516-001	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N019516-002	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N019516-003	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N019516-004	AB	1	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N019516-005	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N019516-001	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N019516-002	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N019516-003	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N019516-004	AB	1	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N019516-005	AB	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N019516-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N019516-002	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N019516-003	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N019516-004	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N019516-005	AB	1	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.